Lin Gui
- Artificial Intelligence top 0.5%
- Topic Modeling 47
- Sentiment Analysis and Opinion Mining 39
- Advanced Text Analysis Techniques 30
- Text and Document Classification Technologies 16
-
- Lymphoma Diagnosis and Treatment 60
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 16
- Oncology top 5%
- Viral-associated cancers and disorders 34
- Hematology top 5%
-
- Nanoplatforms for cancer theranostics 18
- Journals
- Journal of Clinical Oncology (6 papers)Blood (6 papers)ACS Applied Nano Materials (6 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Lin Gui
300 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 191
- Artificial Intelligence 1.8k
- Pathology and Forensic Medicine 432
- Genetics 249
- Oncology 480
- Hematology 170
Countries citing papers authored by Lin Gui
This map shows the geographic impact of Lin Gui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Gui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Gui more than expected).
Fields of papers citing papers by Lin Gui
This network shows the impact of papers produced by Lin Gui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Gui. The network helps show where Lin Gui may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lin Gui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 6 | |
| 12 | 2023 | 0 | |
| 13 | 2023 | 3 | |
| 14 | 2022 | 10 | |
| 15 | 2022 | 36 | |
| 16 | 2022 | 72 | |
| 17 | 2020 | 7 | |
| 18 | 2020 | 1 | |
| 19 | 2020 | 67 | |
| 20 | 2017 | 28 |
About Lin Gui
Lin Gui is a scholar working on Pathology and Forensic Medicine, Oncology, Otorhinolaryngology, Artificial Intelligence and Genetics, having authored 333 papers that have together received 4.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (60 papers), Topic Modeling (47 papers), Sentiment Analysis and Opinion Mining (39 papers), Viral-associated cancers and disorders (34 papers), Advanced Text Analysis Techniques (30 papers), Nanoplatforms for cancer theranostics (18 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Text and Document Classification Technologies (16 papers). The work is most often cited by research in Artificial Intelligence (1.8k citations), Pathology and Forensic Medicine (432 citations), Genetics (249 citations), Oncology (480 citations) and Hematology (170 citations). Lin Gui has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Ruifeng Xu, Yulan He, Bin Liang, Jiachen Du, Qin Lu, Erik Cambria, Hang Su, Ruifeng Xu, Min Yang and Gabriele Pergola. Their work appears in journals such as Journal of Clinical Oncology, Blood, ACS Applied Nano Materials, IEEE Transactions on Broadcasting and Materials Research Express.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.